Intraductal laser ablation during ductoscopy in patients with pathological nipple discharge
Intraductal laser ablation during ductoscopy in patients with papillary lesions seems to be feasible and safe. The Thulium laser enables ablation of residual lesions and is therefore suitable for an immediate second intervention after ductoscopic removal of intraductal lesions. Further refinement and validation in a follow-up clinical trial are necessary to further assess its therapeutic efficacy.
Authors
- Menno R. Vriens (ORCID: https://orcid.org/0000-0003-0521-1125)
- P. J. van Diest (ORCID: https://orcid.org/0000-0003-0658-2745)
- Arjen J. Witkamp (ORCID: https://orcid.org/0000-0002-0313-8844)
- Seher Makineli (ORCID: https://orcid.org/0000-0002-1726-3160)
Institutions
- University Medical Center (US)
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1007/s10549-024-07568-4
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- KWF Kankerbestrijding
- Stichting voor de Technische Wetenschappen